Human papillomavirus-associated tumors of the skin and mucosa - 11/09/11
Abstract |
This review discusses diseases of the lower genital tract in which the presence of human papillomavirus (HPV) DNA is well documented. We discuss epidemiologic, clinical, and experimental data supporting a causative role for HPV in mucosal malignancies, with emphasis on the role of viral and host factors in their pathogenesis. Of special interest is the recently discovered association of cutaneous tumors with HPVs, previously known only for tumors in epidermodysplasia verruciformis (EV). The frequent detection of EV-specific or EV-related HPVs in immunosuppressed persons and in cutaneous tumors in the general population supports the importance of EV as a model of cutaneous oncogenesis. We also discuss recent serologic findings based on enzyme-linked immunosorbent assay results with the use of viruslike particles. This is important both for detection of present or past HPV infection and for epidemiologic and immunologic studies. Novel therapeutic modalities for HPV tumors and prospects for prophylactic and therapeutic vaccination are presented.
Learning objective: |
At the conclusion of this learning activity, participants should be able to recognize the clinical characteristics of the most common malignant disorders associated with high-risk mucosal HPVs or cutaneous and EV-related HPVs. Participants should also be familiar with epidemiologic data on HPV-associated tumors and with basic concepts of the role of HPV genes and host factors in cutaneous and mucosal oncogenesis.
Le texte complet de cet article est disponible en PDF. The CME articles are made possible through an educational grant from the Dermatological Division, Ortho Pharmaceutical Corporation. |
Vol 36 - N° 5
P. 659-685 - mai 1997 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?